Inventiva IVA Stock
Inventiva Price Chart
Inventiva IVA Financial and Trading Overview
| Inventiva stock price | 3.55 USD |
| Previous Close | 3.91 USD |
| Open | 4.23 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1100 |
| Day's Range | 3.99 - 4.65 USD |
| 52 Week Range | 2.22 - 11.75 USD |
| Volume | 804.53K USD |
| Avg. Volume | 137.94K USD |
| Market Cap | 194.97M USD |
| Beta (5Y Monthly) | 1.170986 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.61 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IVA Valuation Measures
| Enterprise Value | 105.63M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.362767 |
| Price/Book (mrq) | 4.2407403 |
| Enterprise Value/Revenue | 5.615 |
| Enterprise Value/EBITDA | -1.876 |
Trading Information
Inventiva Stock Price History
| Beta (5Y Monthly) | 1.170986 |
| 52-Week Change | -33.040% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.75 USD |
| 52 Week Low | 2.22 USD |
| 50-Day Moving Average | 3.09 USD |
| 200-Day Moving Average | 4.39 USD |
IVA Share Statistics
| Avg. Volume (3 month) | 137.94K USD |
| Avg. Daily Volume (10-Days) | 695.6K USD |
| Shares Outstanding | 41.28M |
| Float | 11.66M |
| Short Ratio | 1.63 |
| % Held by Insiders | 0% |
| % Held by Institutions | 13.65% |
| Shares Short | 75.88K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.18% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -288.47% |
| Operating Margin (ttm) | -303.80% |
| Gross Margin | 94.71% |
| EBITDA Margin | -299.31% |
Management Effectiveness
| Return on Assets (ttm) | -30.020% |
| Return on Equity (ttm) | -80.80% |
Income Statement
| Revenue (ttm) | 18.81M USD |
| Revenue Per Share (ttm) | 0.45 USD |
| Quarterly Revenue Growth (yoy) | 142.79% |
| Gross Profit (ttm) | 18.81M USD |
| EBITDA | -56314000 USD |
| Net Income Avi to Common (ttm) | -54274000 USD |
| Diluted EPS (ttm) | -1.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 87.02M USD |
| Total Cash Per Share (mrq) | 2.07 USD |
| Total Debt (mrq) | 44.39M USD |
| Total Debt/Equity (mrq) | 97.61 USD |
| Current Ratio (mrq) | 3.465 |
| Book Value Per Share (mrq) | 1.08 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44928000 USD |
| Levered Free Cash Flow (ttm) | -20659624 USD |
Profile of Inventiva
| Country | United States |
| State | N/A |
| City | Daix |
| Address | 50 rue de Dijon |
| ZIP | 21121 |
| Phone | 33 3 80 44 75 00 |
| Website | https://www.inventivapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 109 |
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Q&A For Inventiva Stock
What is a current IVA stock price?
Inventiva IVA stock price today per share is 3.55 USD.
How to purchase Inventiva stock?
You can buy IVA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Inventiva?
The stock symbol or ticker of Inventiva is IVA.
Which industry does the Inventiva company belong to?
The Inventiva industry is Biotechnology.
How many shares does Inventiva have in circulation?
The max supply of Inventiva shares is 52.98M.
What is Inventiva Price to Earnings Ratio (PE Ratio)?
Inventiva PE Ratio is now.
What was Inventiva earnings per share over the trailing 12 months (TTM)?
Inventiva EPS is -2.61 USD over the trailing 12 months.
Which sector does the Inventiva company belong to?
The Inventiva sector is Healthcare.
Inventiva IVA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}